Biaryl compound and use thereof
US7507753B2 · kind B2 · utility
1Cited by
8References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 26, 2002 |
| Grant date | Mar 24, 2009 |
| Priority date | — |
| Expiry date | Jul 27, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound having melanocortin receptor agonist activity or antagonist activity, which is a novel biaryl compound represented by the formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.